analyst
NYSE · ZBH
Zimmer Biomet Holdings, Inc.
Healthcare · Medical - Devices
$97.06
Up+$15.49 (+15.95%)
Updated Nov 4, 2026, 3:59 PM
SID Score
6.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 18.32B
- P/E ratio
- 22.74
- Dividend yield
- 0.99%
- 52-week range
- $79.12 – $102.86
- Volume
- 3.03M
- Avg. volume
- 1.84M
Price performance · ZBH
ZBH price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
ZBH closed at $97.06 after 21 trading sessions, up 8.23% for the selected period.
- Last close
- $97.06
- Period change
- +8.23%
- Period low
- $88.49
- Period high
- $98.81
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $96.49 | $97.82 | $96.07 | $97.06 | 3.03M |
| Nov 2, 2026 | $95.09 | $97.35 | $94.50 | $97.35 | 2.58M |
| Oct 30, 2026 | $95.84 | $97.32 | $94.38 | $94.52 | 3.61M |
| Oct 29, 2026 | $97.33 | $97.99 | $96.2601 | $97.47 | 2.04M |
| Oct 28, 2026 | $95.33 | $96.74 | $95.10 | $96.39 | 2.17M |
| Oct 27, 2026 | $96.60 | $97.22 | $95.10 | $96.06 | 1.73M |
| Oct 26, 2026 | $97.70 | $98.515 | $96.20 | $97.44 | 2.68M |
| Oct 23, 2026 | $98.37 | $99.3199 | $97.415 | $98.56 | 2.02M |
| Oct 22, 2026 | $95.96 | $98.92 | $95.425 | $98.81 | 2.22M |
| Oct 21, 2026 | $94.60 | $97.00 | $94.03 | $94.86 | 1.45M |
| Oct 20, 2026 | $96.12 | $96.90 | $94.76 | $96.00 | 1.21M |
| Oct 19, 2026 | $94.29 | $95.47 | $93.8505 | $94.99 | 1.15M |
| Oct 16, 2026 | $95.00 | $95.905 | $94.2401 | $94.98 | 1.94M |
| Oct 15, 2026 | $93.56 | $94.85 | $93.225 | $94.38 | 1.86M |
| Oct 14, 2026 | $92.20 | $92.61 | $90.65 | $91.77 | 1.89M |
| Oct 13, 2026 | $92.87 | $93.85 | $91.39 | $92.08 | 2.3M |
| Oct 12, 2026 | $89.28 | $92.23 | $89.18 | $92.17 | 1.8M |
| Oct 9, 2026 | $88.93 | $90.21 | $88.40 | $89.14 | 1.6M |
| Oct 8, 2026 | $88.36 | $89.07 | $87.31 | $88.88 | 2.51M |
| Oct 7, 2026 | $89.11 | $90.0087 | $88.32 | $88.49 | 1.99M |
| Oct 6, 2026 | $91.41 | $91.95 | $89.55 | $89.68 | 1.68M |
Latest ZBH news
The latest Smart Investors Daily articles mentioning ZBH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ZBH research
Overview
Company profile and research snapshot.
Company profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $112.29
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 22, 2026 | Argus Research | Buy | — |
| Oct 7, 2026 | Barclays | Equal-Weight | — |
| Aug 10, 2026 | Canaccord Genuity | Hold | — |
| Aug 7, 2026 | Truist Securities | Hold | — |
| Aug 6, 2026 | Bernstein | Market Perform | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.